▶ 調査レポート

気道陽圧装置のグローバル市場(~2027):自動-気道陽圧滴定、Bi-レベル気道陽圧、持続気道陽圧

• 英文タイトル:Positive Airway Pressure Devices Market Research Report by Product Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Positive Airway Pressure Devices Market Research Report by Product Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「気道陽圧装置のグローバル市場(~2027):自動-気道陽圧滴定、Bi-レベル気道陽圧、持続気道陽圧」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2303F0213
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、244ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査資料は、2021年に1,688.64百万ドルであった世界の気道陽圧装置市場規模が、2022年に1,805.36百万ドルになり、2027年まで年平均7.08%で成長して2,546.89百万ドルに到達すると予想しています。本調査資料では、気道陽圧装置の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品種類別(自動-気道陽圧滴定、Bi-レベル気道陽圧、持続気道陽圧)分析、エンドユーザー別(在宅医療、病院&睡眠研究所)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などを以下の構成でまとめております。さらに、市場参入企業として、3B Medical, Inc.、Apex Medical Corp.、Armstrong Medical Inc.、Becton, Dickinson and Company、BMC Medical Co., Ltd.、Breas Medical AB、Compumedics Limited、Drive DeVilbiss Healthcare, Inc.、Dymedso Inc.、Fisher & Paykel Healthcare Limited、Invacare Corporation、Koninklijke Philips N.V.、medin Medical Innovations GmbH、Microchip Technology Inc.、Narang Medical Limited、Nice Neotech Medical Systems Private Limitedなどの情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の気道陽圧装置市場規模:製品種類別
- 自動-気道陽圧滴定装置の市場規模
- Bi-レベル気道陽圧装置の市場規模
- 持続気道陽圧装置の市場規模
・世界の気道陽圧装置市場規模:エンドユーザー別
- 在宅医療における市場規模
- 病院&睡眠研究所における市場規模
・世界の気道陽圧装置市場規模:地域別
- 南北アメリカの気道陽圧装置市場規模
アメリカの気道陽圧装置市場規模
カナダの気道陽圧装置市場規模
ブラジルの気道陽圧装置市場規模
...
- アジア太平洋の気道陽圧装置市場規模
日本の気道陽圧装置市場規模
中国の気道陽圧装置市場規模
インドの気道陽圧装置市場規模
韓国の気道陽圧装置市場規模
台湾の気道陽圧装置市場規模
...
-ヨーロッパ/中東/アフリカの気道陽圧装置市場規模
イギリスの気道陽圧装置市場規模
ドイツの気道陽圧装置市場規模
フランスの気道陽圧装置市場規模
ロシアの気道陽圧装置市場規模
...
-その他地域の気道陽圧装置市場規模
・競争状況
・企業情報

The Global Positive Airway Pressure Devices Market size was estimated at USD 1,688.64 million in 2021 and expected to reach USD 1,805.36 million in 2022, and is projected to grow at a CAGR 7.08% to reach USD 2,546.89 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Positive Airway Pressure Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Auto – Titrating Positive Airway Pressure, Bi – level Positive Airway Pressure, and Continuous Positive Airway Pressure.

Based on End User, the market was studied across Home Care Settings and Hospitals & Sleep Labs.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Positive Airway Pressure Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Positive Airway Pressure Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Positive Airway Pressure Devices Market, including 3B Medical, Inc., Apex Medical Corp., Armstrong Medical Inc., Becton, Dickinson and Company, BMC Medical Co., Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Inc., Dymedso Inc., Fisher & Paykel Healthcare Limited, Invacare Corporation, Koninklijke Philips N.V., medin Medical Innovations GmbH, Microchip Technology Inc., Narang Medical Limited, Nice Neotech Medical Systems Private Limited, NXP semiconductor NV, ResMed Corp., Salter Labs Inc., Smiths Medical, Teijin Pharma Limited, and Texas Instruments Incorporated.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Positive Airway Pressure Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Positive Airway Pressure Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Positive Airway Pressure Devices Market?
4. What is the competitive strategic window for opportunities in the Global Positive Airway Pressure Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Positive Airway Pressure Devices Market?
6. What is the market share of the leading vendors in the Global Positive Airway Pressure Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Positive Airway Pressure Devices Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence and economic burden caused by sleep apnea
5.1.1.2. Increased awareness about obstructive sleep apnea and its treatment options
5.1.1.3. Technology developments in diagnostics related to sleep apnea
5.1.1.4. Prevalence of Respiratory Diseases among the geriatric population
5.1.2. Restraints
5.1.2.1. Stringent regulations on device approvals
5.1.3. Opportunities
5.1.3.1. Attractiveness of continuous positive airway pressure therapy
5.1.3.2. Digitisation of training modules for patients
5.1.4. Challenges
5.1.4.1. Patient challenge with continuous device usability
5.2. Cumulative Impact of COVID-19

6. Positive Airway Pressure Devices Market, by Product Type
6.1. Introduction
6.2. Auto – Titrating Positive Airway Pressure
6.3. Bi – level Positive Airway Pressure
6.4. Continuous Positive Airway Pressure

7. Positive Airway Pressure Devices Market, by End User
7.1. Introduction
7.2. Home Care Settings
7.3. Hospitals & Sleep Labs

8. Americas Positive Airway Pressure Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Positive Airway Pressure Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Positive Airway Pressure Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 3B Medical, Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Apex Medical Corp.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Armstrong Medical Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Becton, Dickinson and Company
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. BMC Medical Co., Ltd.
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Breas Medical AB
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Compumedics Limited
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Drive DeVilbiss Healthcare, Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Dymedso Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Fisher & Paykel Healthcare Limited
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Invacare Corporation
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Koninklijke Philips N.V.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. medin Medical Innovations GmbH
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Microchip Technology Inc.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Narang Medical Limited
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Nice Neotech Medical Systems Private Limited
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. NXP semiconductor NV
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. ResMed Corp.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Salter Labs Inc.
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Smiths Medical
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Teijin Pharma Limited
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Texas Instruments Incorporated
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing